China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
16.67
+1.07 (6.86%)
Jun 29, 2026, 3:00 PM CST
SHA:600062 Market Cap
SHA:600062 has a market cap or net worth of 17.22 billion as of June 29, 2026. Its market cap has decreased by -14.09% in one year.
Market Cap
17.22B
Enterprise Value
16.72B
Revenue
10.73B
Ranking
n/a
PE Ratio
10.63
Stock Price
16.67
Market Cap Chart
Since March 1, 2004, SHA:600062's market cap has increased from 9.40B to 17.22B, an increase of 83.09%. That is a compound annual growth rate of 2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 17.22B | -8.84% |
| Dec 31, 2025 | 18.89B | -7.08% |
| Dec 31, 2024 | 20.32B | 5.43% |
| Dec 29, 2023 | 19.28B | 5.47% |
| Dec 30, 2022 | 18.28B | 31.03% |
| Dec 31, 2021 | 13.95B | 11.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghong Pharmaceutical Group | 17.98B |
| Apeloa Pharmaceutical Co.,Ltd | 17.97B |
| Hybio Pharmaceutical | 17.46B |
| Dizal (Jiangsu) Pharmaceutical | 16.97B |
| Kangmei Pharmaceutical | 16.73B |
| Joincare Pharmaceutical Group Industry | 16.58B |
| Shandong Buchang Pharmaceuticals | 15.15B |
| ApicHope Pharmaceutical Group | 14.58B |